|
|
|
Volumn 18, Issue 102, 2009, Pages 165-
|
|
Bevacizumab + sunitinib: microangiopathic haemolytic anaemia. A serious drug interaction between 2 cancer drugs.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
INDOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
PYRROLE DERIVATIVE;
SUNITINIB;
VASCULOTROPIN A;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG INTERACTION;
HEMOLYTIC ANEMIA;
HUMAN;
ANEMIA, HEMOLYTIC;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG INTERACTIONS;
HUMANS;
INDOLES;
PYRROLES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 70349577777
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|